Join
Live feed
·
NEWSReleasevia Quantisnow
Freeline Therapeutics Holdings plc logo

HC Wainwright & Co. Downgrades Freeline Therapeutics to Neutral, Lowers Price Target to $6.5

ByQuantisnow·Wall Street's wire, on your screen.
FRLN· Freeline Therapeutics Holdings plc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FRLN (Freeline Therapeutics Holdings plc) and more on Quantisnow.